Breathlessness in COPD: linking symptom clusters with brain activity by Finnegan, S.L. et al.
Breathlessness in COPD: linking symptom clusters with 
brain activity
FINNEGAN, S.L., HARRISON, O.K., HARMER, C.J., HERIGSTAD, Mari, 
RAHMAN, N.M., REINECKE, A. and PATTINSON, K.T.S.
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/29501/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
FINNEGAN, S.L., HARRISON, O.K., HARMER, C.J., HERIGSTAD, Mari, RAHMAN, 
N.M., REINECKE, A. and PATTINSON, K.T.S. (2021). Breathlessness in COPD: 
linking symptom clusters with brain activity. European Respiratory Journal, 58 (5), p. 
2004099. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
Breathlessness in COPD: linking symptom clusters with brain
activity
Sarah L. Finnegan 1, Olivia K. Harrison1,2,3, Catherine J. Harmer4,5, Mari Herigstad6, Najib M. Rahman7,8,
Andrea Reinecke4 and Kyle T.S. Pattinson1
1Wellcome Centre for Integrative Neuroimaging and Nuffield Division of Anaesthetics, Nuffield Dept of Clinical Neurosciences,
University of Oxford, Oxford, UK. 2Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and
ETH Zurich, Zurich, Switzerland. 3School of Pharmacy, University of Otago, Dunedin, New Zealand. 4Dept of Psychiatry, Medical
Sciences Division, University of Oxford, Oxford, UK. 5Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK. 6Dept of
Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK. 7Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
8NIHR Oxford Biomedical Research Centre, Oxford, UK.
Corresponding author: Sarah L. Finnegan (sarah.finnegan@ndcn.ox.ac.uk)
Shareable abstract (@ERSpublications)
Towards individualised treatments for chronic breathlessness with functional neuroimaging:
revealing the factors underlying the breathlessness experience in COPD https://bit.ly/3a8fXPt
Cite this article as: Finnegan SL, Harrison OK, Harmer CJ, et al. Breathlessness in COPD: linking
symptom clusters with brain activity. Eur Respir J 2021; 58: 2004099 [DOI: 10.1183/13993003.04099-
2020].
Abstract
Background Current models of breathlessness often fail to explain disparities between patients’
experiences of breathlessness and objective measures of lung function. While a mechanistic understanding
of this discordance has thus far remained elusive, factors such as mood, attention and expectation have all
been implicated as important modulators of breathlessness. Therefore, we have developed a model to better
understand the relationships between these factors using unsupervised machine learning techniques.
Subsequently we examined how expectation-related brain activity differed between these symptom-defined
clusters of participants.
Methods A cohort of 91 participants with mild-to-moderate chronic obstructive pulmonary disease
(COPD) underwent functional brain imaging, self-report questionnaires and clinical measures of respiratory
function. Unsupervised machine learning techniques of exploratory factor analysis and hierarchical cluster
modelling were used to model brain–behaviour–breathlessness links.
Results We successfully stratified participants across four key factors corresponding to mood, symptom
burden and two capability measures. Two key groups resulted from this stratification, corresponding to
high and low symptom burden. Compared with the high symptom burden group, the low symptom burden
group demonstrated significantly greater brain activity within the anterior insula, a key region thought to be
involved in monitoring internal bodily sensations (interoception).
Conclusions This is the largest functional neuroimaging study of COPD to date, and is the first to provide
a clear model linking brain, behaviour and breathlessness expectation. Furthermore, it was possible to
stratify participants into groups, which then revealed differences in brain activity patterns. Together, these
findings highlight the value of multimodal models of breathlessness in identifying behavioural phenotypes
and for advancing understanding of differences in breathlessness burden.
Introduction
For the millions of people living with chronic obstructive pulmonary disease (COPD), asthma, heart
failure, cancer and survivors of intensive care, chronic breathlessness is a major source of suffering.
Breathlessness extends pervasively into people’s lives, and carries substantial personal, social and
economic impact [1–3]. Adding to the burden of COPD and impeding its effective clinical care is the
subjective nature of breathlessness, which corresponds poorly with objective disease markers and clinical
estimations of severity [4]. While traditional models of breathlessness fail to explain this discordance,
recent work in asthma [5] has highlighted that the one-to-one coupling between symptom and disease
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severity exists only as a small part of a wider spectrum. At one end of this spectrum a person with
relatively mild disease may find themselves disabled by feelings of breathlessness (symptom predominant),
while conversely, others with severe disease may suffer less and have a considerably better quality of life
(e.g. inflammation predominant) [5].
While conventional thinking has viewed breathlessness as a symptom arising directly from lung disease or
cardiopulmonary stress, neuroimaging studies are beginning to reveal the key role of the brain in
generating and maintaining breathlessness perception [6–9]. Within these models, breathlessness may not
simply arise from the current patho-physiological status of the lungs and airways, but rather as a complex
product of previous experiences, expectations, emotional state and perception of internal sensory signals [10].
The importance of considering breathlessness as a multisystem experience is stressed by the 2012
American Thoracic Society statement, which highlighted the link between the neural systems subserving
breathlessness and that of chronic pain [3]. While the field of chronic pain research has taken strides
towards generating neuro-biomarkers [11–14], which may sit within individualised treatment pathways in
the future [15], similar applications in chronic breathlessness are in their infancy. The foundations for this
work are in place; stratification techniques have been used in COPD, asthma and other cardiorespiratory
diseases to examine patients in terms of comorbidities and clinically relevant groupings of physiology
and psychology [5, 10, 16, 17]. Additionally, neuro-psychological phenotypes have been proposed for
asthma [18]. However, data-driven models exploring the psychological factors of breathlessness and their
variability across individuals have yet to be formalised in COPD.
Experimental studies in both healthy adults and patients with COPD have used both resistive loads [8, 19–25]
and air hunger [26–28] to examine breathlessness-related brain activity. Of these methods, air hunger is
thought to most closely mirror the unpleasantness experienced in chronic breathlessness [29]. However, as
breathlessness is a multidimensional experience [3, 30, 31], the approach taken should differ depending on
the dimension under scrutiny and the clinical translation in mind. Thus, while laboratory-induced
sensational cues and breathing work/effort may examine the physical experience of breathlessness, this
study focuses on other important aspects of breathlessness, including the long-term lived experience of
breathlessness perception, expectation and emotional responses.
A body of evidence now links symptom perception with expectation [32–34]. This is particularly relevant
for populations with chronic symptoms of breathlessness, where the emotion and expectation of
breathlessness–cue relationships are deeply complex and entrenched. Even in healthy volunteers, the
expectation alone of a breathless-inducing situation, such as an odorous gas, can be sufficient to drive
brain activity patterns and resulting breathlessness in the absence of afferent input [34].
Here we translated an experimental anticipation paradigm, often undertaken in healthy volunteers, into a
more clinically relevant design. In doing so we aimed to better understand breathlessness-expectation-
related brain activity and the interaction between behavioural, physiological and psychological factors of
breathlessness, within the individual. To achieve this, we applied unsupervised machine learning
techniques to outcomes derived from a cohort of 91 patients with COPD, using standardised measurements
of physiology as well as comprehensive psychological and behavioural tests. We used these measures to
examine the relationship between brain activity, behaviour and breathlessness across individuals, and aimed
to stratify participants into potentially therapeutically relevant groupings.
Methods and materials
Participants
100 participants (36 females, median (range) age 70 (49–84) years) with mild-to-moderate COPD
(according to Global Initiative for Chronic Obstructive Lung Disease standards) were recruited immediately
prior to their enrolment in a National Health Service-prescribed course of pulmonary rehabilitation. From
this population, 91 participants completed the magnetic resonance imaging (MRI) component of the study
(table 1). Reasons for non-completion of the MRI scan are detailed in figure 1. The data presented here
correspond to the participants’ first (baseline) study visit as part of a wider investigation of the effects of
D-cycloserine on pulmonary rehabilitation outcome (to be published separately). Written informed consent
was obtained prior to the start of the study. Study approval was granted by South Central Oxford Research
Ethics Committee B (118784). Study inclusion criteria included a diagnosis of COPD and admittance to
pulmonary rehabilitation. Exclusion criteria included inadequate understanding of verbal and written
English, significant cardiac, psychiatric (including depression under tertiary care) or metabolic disease
(including insulin-controlled diabetes), stroke, contraindications to D-cycloserine (including alcoholism),
epilepsy, claustrophobia, regular therapy with opioid analgesics, or oxygen therapy.
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Excluded (study exclusion 
  criteria, scheduling difficulties) 
  (n=293)
Excluded (not meeting inclusion 
  criteria) (n=11)
Excluded (not meeting inclusion 
  criteria) (n=9)
FIGURE 1 Flowchart of the stages of participant recruitment, reasons for exclusion and total number of
completed participant datasets. MRI: magnetic resonance imaging.
TABLE 1 Demographic information
Participants 91
Median (range) age years 70 (49–84)
BMI kg·m−2 27.1 (6.6)
Smoking pack-years 30 (27.4)
Resting SpO2 % 94 (3)
Resting heart rate beats·min−1 81.1±12.7
FEV1/FVC 0.55±0.15
FEV1 % pred 58±21
MRC 3 (1)
Age at onset years 62±10
Duration of breathlessness years 8 (10.5)





Swelling of ankles 20












Data are presented as n, median (interquartile range) or mean±SD, unless otherwise stated. BMI: body mass
index; SpO2: peripheral blood oxygen saturation; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity;
MRC: Medical Research Council.
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Behavioural measures
Self-report questionnaires
Building on our previous work [6, 7], we selected a set of questionnaires designed to probe the experience of
living with COPD, focusing particularly on the potential influence of emotional and behavioural measures.
The following self-report questionnaires were completed and scored according to their respective manuals:
Dyspnoea-12 (D12) questionnaire [35], Centre for Epidemiologic Studies Depression Scale [36],
State-Trait Anxiety Inventory Trait [37], Fatigue Severity Scale [38], St George’s Respiratory
Questionnaire (SGRQ) [39], Medical Research Council (MRC) breathlessness scale [40], Mobility
Inventory [41], Pittsburgh Sleep Quality Index [42], Catastrophic Thinking Scale in Asthma [43], and Pain
Awareness and Vigilance Scale [44].
Physiological measures
Spirometry and two modified shuttle walk tests (MSWTs) were collected using standard protocols [45, 46].
Participant height and weight were recorded.
MRI measures
Image acquisition
Imaging was carried out using a 3 T MAGNETOM Trio (Siemens Healthcare, Malvern, PA, USA). A
T1-weighted (MPRAGE) structural scan (voxel size 1×1×1 mm) was collected and used for registration
purposes. A T2*-weighted, gradient echo planar image scan sequence (voxel size 3×3×3 mm) was used to
collect functional imaging data during the word-cue and faces task.
Word-cue task
Given sufficient repeated threatening exposures, the thought alone of a breathlessness-evoking situation
such as climbing the stairs or having to hurry can prime brain networks that then exacerbate breathlessness
itself. The resulting top-down cascade can even drive breathlessness perception in the absence of afferent
inputs. We drew on this well-recognised link [47–49] to indirectly probe the brain’s prior associations with
breathlessness with a salient word-cue task [50]. Breathlessness-related word cues were selected to include
a dynamic range of scenarios. In this instance, the presentation of breathlessness-related word cues can be
considered as similar to a conditioned stimulus, triggering the brain networks associated with the real-life
situation itself. During functional MRI (fMRI) scanning participants were shown a set of breathlessness-
related word cues in white text on a black background for 7 s in a pseudo-randomised order. Participants
were then asked “How breathless would this make you feel” (words-breathlessness (wB)) and “How
anxious would this make you feel?” (words-anxiety (wA)). To each question participants responded within
a 7-s window using a button box and visual analogue scale (VAS). The response marker always initially
appeared at the centre of the scale with the anchors “Not at all” and “Very much” at either end. Before the
scan session participants were given the opportunity to practice using the button box with a set of test
words. A control condition consisting of a string of “XXXXXXXXXXXXXXX” with fixed length of 15
characters was presented four times over the course of the scan, each time for 7 s, and was used as a
baseline measure of activity in response to the presentation of a visual stimulus. Any resulting significant
activity could be ascribed to expectation-related processes triggered by the meaning of the words. No
rating period followed these control blocks (supplementary figure S1). This analysis could be considered as
similar to an expectation paradigm in which the brain activity relating to breathlessness-related word cues
(controlled for visual effects of the non-words) represents the brain response to breathlessness expectation.
The resulting brain activity patterns therefore provide a window into the processes of breathlessness
perception and expectation.
Faces task
In order to dissociate the brain’s responses relating to breathlessness-specific anxiety from generalised
anxiety we employed a second validated paradigm involving emotional faces [51]. Emotional facial
expressions are widely recognised to activate the same brain pathways as the behavioural emotion
conveyed by the expression itself [52]. Fearful facial expressions, for example, have been shown to
correspond to activity within the amygdala, a region known to modulate fear processing. The speed and
accuracy of task completion, which in this instance was the recognition of facial gender, under different
emotional conditions can be used probe whether attention is affected by the emotion shown by the face.
This draws upon work suggesting that the threat of breathlessness may absorb cognitive resources [53, 54].
Biased attentional processes, either towards or away from potentially threatening situations, may be
mirrored by activity patterns within threat and fear brain networks. In this task, participants were shown
human faces with either happy or fearful expressions (100% intensity) for 500 ms (drawn from the set
described in [51]) in blocks of 30 s. A fixation cross was interspersed for 30 s between the blocks of faces.
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Reaction time and accuracy were recorded throughout the task. Further details pertaining to facial stimuli
can be found within the supplementary material.
Analysis
Behavioural analysis: factor identification
Full correlation matrices were calculated for (z-scored) behavioural questionnaires and physiological scores
(spirometry, demographics and MSWT measures), using MATLAB 2017b (Mathworks, Natick, MA,
USA). All included measures are shown in figure 2 and a list of these measures is included in the
supplementary material. The structure of the correlation matrices was examined by applying a hierarchical
cluster model to the data (supplementary figure S3). Hierarchical models use the covariance across groups
of measures in order to organise them spatially within the correlation matrix [55–57]. The dataset was then
visualised in figure 2 as a connectogram; a circular representation of interdependencies between measures.
An exploratory factor analysis (EFA) was conducted to formalise these relationships [58–60]. EFA is a
statistical method that uncovers latent (hidden) factors within a dataset.
Behavioural analysis: participant stratification
A principal component analysis was performed across the measures within each factor, identified via the EFA





























































































FIGURE 2 Connectogram: measures are plotted as a wheel with connections between each measure shown as
a thread; the thickness of the thread provides a visual representation of the strength of the relationship
between any two measures (r⩾0.35). SGRQ: St George’s Respiratory Questionnaire; D12: Dyspnoea-12; MSWT:
modified shuttle walk test; HR: heart rate; MRC: Medical Research Council; SpO2: peripheral blood oxygen
saturation; BMI: body mass index. Coloured dots highlight the common factors underlying groups of measures.
Pink dots correspond to Factor 4 (Mood), red to Factor 1 (Symptom burden), yellow to Factor 2 (Physical
capability) and blue to Factor 3 (Perceived capability).
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anonymised subject identities. A scree plot was used to identify the most statistically distinct groupings of
participants (supplementary figure S6). The fMRI data was held out of the participant stratification process in
order to provide independent validation of any resulting group differences at a later stage.
Imaging analysis
Image processing was carried out using the Oxford Centre for Functional Magnetic Resonance Imaging of
Brain Software Library (FMRIB, Oxford, UK; FSL version 5.0.8; www.fmrib.ox.ac.uk/fsl), MATLAB
(R2017b) and associated custom scripts. MRI processing was performed using FEAT (FMRI Expert
Analysis Tool, within the FSL package).
Word-cue task lower-level analysis
At the individual subject level, a general linear model (GLM) was created with explanatory variables for
breathlessness-related word or non-word presentation, and two de-meaned explanatory variables modelling
the reported breathlessness (wB) and anxiety (wA) response to the word cues. The word cues represented a
wide range of breathlessness-inducing situations. These ranged from very low impact activities such as
quiet reading to high impact activities such as heavy lifting. Including ratings for each word in a first stage
analysis allows for the variability between word cues to be incorporated into the model. An additional
explanatory noise variable was included as a separate regressor to model the period during which the
participant responded using the VAS. In addition to the mean contrasts for each of the explanatory
variables, differential contrasts were also created for activity in response to breathlessness-related words
greater than that for non-words and for non-words greater than that for breathlessness-related words
(supplementary figure S2). It was this contrast of breathlessness-related words greater than for non-words
that was of interest in the group-level analysis.
Faces task lower-level analysis
At the individual subject level, a GLM was created with explanatory variables for stimulus presentation
periods of happy and fearful faces, along with the associated (de-meaned) reaction times. Two additional
explanatory variables were created to model participant (de-meaned) accuracy in identifying whether the
presented faces were male or female. In addition to the mean contrasts for each of the explanatory
variables, differential contrasts were also created for activity in response to fearful faces greater than that
for happy faces.
Group-level analysis
We then performed a cross-subject analysis to examine the expectation-related responses to
breathlessness-related cues. This could be considered as similar to an anticipation paradigm in which
chronic breathlessness participants are already primed to potential triggers of breathlessness. Mean
voxel-wise differences in activity were calculated for the breathlessness-related words>non-words,
non-words>breathlessness-related words. This allowed us to examine the brain activity resulting from
automatic cued breathlessness perceptions generated by the breathlessness-related words. Contrasts were
also created for fearful faces>happy faces, happy faces>fearful faces for the faces task. For both tasks,
contrasts were also employed to examine the differences between the two groups of participants
(corresponding to high and low symptom load) identified within the hierarchical cluster model at the
participant stratification stage. In an additional analysis we asked the question “Does the relationship
between expectation-related brain activity and word-cue ratings differ in our two behaviourally-defined
groups?”. To answer this question, contrasts were also created between high and low symptom burden
groups to examine brain activity that covaried with breathlessness anxiety (wA) and breathlessness
intensity (wB) ratings. De-meaned age and sex values were modelled as regressors of no interest.
Significance testing was performed using FSL’s Randomise tool [61], which carries out rigorous
permutation testing, with threshold-free cluster enhancement (TFCE) (a non-parametric test) [62] at
family-wise error corrected p<0.05. Based on a priori hypotheses, a region of interest (ROI) approach,
examining differential activity specifically within the amygdala (including 10-mm radius spherical masks
based around a previously published peak voxels of a left amygdala region (−14/−6/−8) and its right
hemisphere counterpart from an emotion regulation paradigm [63]), was also taken. This choice was driven
by our previous work showing that this amygdala mask sensitively differentiates between patients with and
without anxiety disorder [64, 65].
Supplementary analysis examined whether brain activity in response to happy or fearful faces differed
between the two groups and is reported within the supplementary material.
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Results
Of the 23 variables entered into the hierarchical cluster model, EFA indicated that 14 should be retained
for model validation. These variables included: Anxiety, Depression, SGRQ Impact, D12, Catastrophising,
Vigilance, Fatigue, SGRQ Symptom, MSWT heart rate change, MSWT distance, SGRQ Activity, MRC,
Avoidance Alone and Avoidance Accompanied. These groups of measures are demonstrated in figure 2
and in supplementary figure S3.
The composite scores of the 14 measures retained by the EFA formed four factors. This final four-factor
model (shown overlaid onto figure 2) was validated after testing for models of two, three and four factors
(χ2=65.85, df=41, p<0.008; Tucker–Lewis index 0.9; root mean square error of approximation 0.05). The
factor diagram shown in figure 3 shows how four latent factors emerged from the 14 variables. Factor 1 is
made up of Vigilance, Catastrophising, Fatigue, SGRQ Symptoms, SGRQ Impact and D12. Factor 2 is
made up of MSWT distance, MSWT heart rate change and SGRQ Activity. Factor 3 is composed of two
of the Avoidance subscales and the MRC scale. Finally, Factor 4 consists of Depression and Anxiety. The
covariance between factors is illustrated by the curved lines in figure 3, with Factors 1 and 4 demonstrating
the strongest covariance (0.5). This relatedness highlights that the factors should be considered as
belonging to one model.
Identifying phenotypes from the latent factors
The factors identified by EFA model fitting were then used to stratify the patient population via their
composite scores on these four major factors in a hierarchical cluster model (figure 4). A scree plot
(supplementary figure S6) confirmed that a two-group solution was the most distinct. The groupings of













































FIGURE 3 Factor loadings. SGRQ: St George’s Respiratory Questionnaire; D12: Dyspnoea-12; MSWT: modified
shuttle walk test; HR: heart rate; MRC: Medical Research Council. The relationship between each variable
(rectangles) and its parent factor (ellipses) is shown. Loadings (straight lines) can be interpreted as correlation
coefficients. The covariance between factors (curved lines) is also shown.
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significant differences between the two groups between each factor at p<0.001. This difference was not
driven by differences in spirometry scores (p=0.94).
MRI results
Mean group differences: word task
In the word-cue task, which was designed to probe the brain’s expectation-related response to
breathlessness-related situations [50], significant group differences were found in response to the
breathlessness-related word cues compared with non-words in the anterior insula (figure 5b) when using
non-parametric permutation testing (TFCE) . The blood oxygen level dependent (BOLD) response within
the low symptom group was found to be higher in this key region in response to breathlessness words
versus non-words (TFCE p<0.05). This difference reflected the generally greater activity observed in the
low symptom load group (6.97±5.42) compared with the high symptom load group (0.03±7.81) (figure 5a
and c). No significant difference was observed within the small volume correction analysis of the
amygdala. In an additional analysis we identified a stronger positive correlation between brain activity and
ratings of breathlessness intensity (but not breathlessness anxiety) in the high symptom load group than the
low symptom load group in the lingual/fusiform gyrus (figure 6).
Participant ratings of the breathlessness-related words were found to be significantly higher in the high
symptom load group (p<0.01) compared with the low symptom load group for both breathlessness anxiety
(wA) (high load 36.7±19.2, low load 10.3±11.2) and breathlessness intensity (wB) (high load 56.0±11.8,
low load 35.4±14.8) (figure 7), both of which were measures that remained independent of the
classification of the participants into groups.
Mean group differences: faces task
In the control task of emotional faces (to test for generalised anxiety), no significant difference in activity
between groups in the condition of fearful versus happy faces was identified. No significant difference was
observed within the small ROI analysis of the amygdala. No significant difference was found in participant
reaction times to happy (high load 758.57±137.92 ms, low load 782.09±107.72 ms) or fearful faces (high











































FIGURE 4 Clustergram: a matrix of each participants’ score across the four key factors identified by exploratory
factor analysis. Factor score is measured in arbitrary units (AU). Participants form the y-axis, while each of the
four factors is shown along the x-axis. A dendrogram is displayed along the left side, highlighting the division
of subjects into two clear groups.
https://doi.org/10.1183/13993003.04099-2020 8
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
Discussion
Key findings
Using unsupervised machine learning we stratified a population of patients with COPD into two groups
based on their scores across four latent (hidden) factors of breathlessness. We have described these factors
as “Mood”, “Symptom burden”, “Anticipated capability” and “Physical capability”. Differences between
the two groups were linked to expectation-related brain activity within the anterior insula, a region















































































FIGURE 5 Blood oxygen level dependent activity in response to breathlessness-related words compared with non-words for a) high and low
symptom load groups separately, and b) their contrast. MFG: middle frontal gyrus; IFG: inferior frontal gyrus; OFC: orbitofrontal cortex; PCG:
paracingulate gyrus; SFG: superior frontal gyrus; SMG: supramarginal gyrus; PCC: posterior cingulate cortex; ACC: anterior cingulate cortex; MTG:
middle temporal gyrus; COPE: contrast of parameter estimate. a) The IFG, MFG and temporal pole demonstrated significant activity in the high
symptom group, while in the low symptom group, the PCG, anterior insular, temporal pole, precuneus, PCC, ACC, SMG, thalamus SFG, MFG and IFG
all demonstrated significant activity. For both high and low symptom groups, significant regions are displayed with a non-parametric threshold-free
cluster enhancement p<0.05. b) The contrast of the two groups revealed significant regional activity in the low symptom group compared with the
high symptom group in the anterior insula cortex with a non-parametric p<0.05. c) Mean COPE in arbitrary units (AU) for the high and low
symptom load groups separately with standard deviation bars showing the variation in parameter estimates across participants.
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of expectation-related brain processes to the lived experience of breathlessness, laying the foundation to
therapeutically target brain processes and thereby address the individual’s experience of breathlessness.
A new mode of investigation for chronic breathlessness
Using a large sample size (91 participants) we were able to better understand variability in breathlessness
perception than previously possible, where sample sizes were smaller. The data-driven analysis approaches
employed offer an effective way to both discover and formalise new relationships within multimodal
datasets such as this one without restricting or biasing the analysis.
In this study, the unsupervised machine learning algorithms indicated that 14 out of the 23 behavioural
measures were important descriptors of the population. While each of these single measures may offer a
partial description of breathlessness, a more powerful approach is to combine relevant measures and draw
out common factors, thus uncovering data trends that may ordinarily be hidden by noise. In this case the
four latent factors that were found to underly scores on these 14 measures together paint an intuitive
picture of the lived experience of breathlessness: what a person feels they can and cannot do, how their
symptoms impact their lives and their general mood.
Physiological measures such as spirometry and pack-years failed to fulfil the criteria of either contributing
uniquely to a single factor or exceeding the required 0.4 weighting score to be considered as strongly

















High symptom load > low symptom load
FIGURE 6 The positive correlation between blood oxygen level dependent activity and breathlessness ratings
was stronger for the high symptom load group than low symptom load group in the lingual gyrus and fusiform
gyrus. Significant regions are displayed with a non-parametric threshold-free cluster enhancement p<0.05.
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this make you feel?"
(wA)
"How breathless would
this make you feel?"
(wB)
FIGURE 7 Participant ratings of breathlessness anxiety (words-anxiety (wA)) and breathlessness intensity
(words-breathlessness (wB)) in response to breathlessness-related words for low and high symptom load
groups. Data are presented as mean±SD for both groups.
https://doi.org/10.1183/13993003.04099-2020 10
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
found to differ between the two groups. These findings highlight that the perception of breathlessness
arises as an interplay between numerous factors, including physiology and the associated neural activity of
expectation-related processes.
Stratifying patients based on latent factors of breathlessness
The four factors produced by the EFA demonstrated significant intra-factor correlations (R=0.4–0.5) and so
should be considered to belong to one model. By using participant scores across these four factors as
inputs into the model-free technique of hierarchical clustering, we were able to examine how weightings
across the factors differed across the patient population. The previously held-out fMRI data were then used
to provide an external validation of the groupings and revealed that these differences appear to be linked to
differences in the processing of breathlessness expectation cues. We identified greater activity in response
to breathlessness-related word cues within the anterior insula for the low symptom burden group than the
high symptom burden group.
Increases in insula activity are commonly reported in studies of induced air hunger [26–28], and in both
the anticipation and application of resistive loads [8, 66–68]. In these studies, insula activity has been
found to be higher in conditions of breathlessness or the anticipation of breathlessness than at baseline.
However, in the current study the lower symptom load group demonstrated greater activity in the anterior
insula. This result implies that a greater level of breathlessness symptom load does not necessarily equate
to a proportionally greater level of associated brain activity and that neural encoding might not be reflected
in a simple linear stimulus–response relationship. An alternative explanation draws on recent work that is
beginning to discuss brain function in terms of networks [69–71], rather than tying specific functions to
particular brain areas [72–74]. Brain regions are now thought to subserve many different functions through
these network interactions, including bodily awareness (interoception) [74, 75].
The anterior insula is part of the wider brain network thought to be involved with the affective perception
of internal sensations and the evaluation of stimuli [76, 77], and has itself been linked with the processing
of subjective feelings [78]. Therefore, the greater activity within the network of the low symptom load
group may be linked to a more coherent representation of internal sensations (i.e. Factors 2 and 3), leading
to lower anxiety and general symptom burden (i.e. scores on Factors 4 and 1). While for the high-burden
group, breathlessness cues may trigger more complex and personal internal representations, resulting in
greater individual variation in brain activity patterns. This hypothesis is in part supported by our findings
of a stronger correlation between activity in the lingual/fusiform gyrus and breathlessness intensity ratings
in the high symptom load group. The lingual/fusiform gyrus resides with the ventral visual processing
stream, a network of regions with well-established specialism for faces, words and objects [79–81]. Via
reciprocal connections with both lower visual and higher cortical areas, the lingual/fusiform gyrus
combines lower-level visual features to extract semantic meaning [82]. In the case of words, activity within
the lingual/fusiform gyrus has been shown to be influenced by emotional content [83], increasing with
negative valence [84]. While there is some evidence to suggest that the lingual gyrus may be connected to
fear- and anxiety-related processes [85, 86], other work has highlighted that greater cognitive demands and
focused attention can also increase brain activity within a “motivated attentional framework” [83, 87, 88].
In this study we demonstrated a stronger positive correlation with breathlessness intensity ratings and brain
activity for the high, compared with low, symptom load group within the lingual/fusiform gyrus. This
finding may reflect a positive relationship between word-cue intensity and attentional demands or one in
which the high symptom load group is more primed by their own previous experiences to increasing
negative salience of the word cues. Either of the cases (which are also not mutually exclusive) could result
in a greater positive correlation between regional brain activity and ratings of breathlessness intensity in
response to the word cue.
Additionally, it is worth noting that the involvement of the lingual/fusiform gyrus may be directly related
to the task (in this case word cues). Another type of cue, e.g. a breathing load or auditory stimulus, would
act via different mechanisms and activate other brain areas. In contrast, the insula takes input, among
others, from sensory processing brain regions. Therefore, the differences in activity observed within the
insula may represent a more “downstream” and therefore more stimulus-independent group difference in
the affective processing of breathlessness expectation.
Further considerations and limitations
The techniques employed here draw upon the big data techniques of machine learning and with further
participants it may be possible to gain sufficient statistical power to further probe subgroups, such as those
visible within figure 4. Such groupings could of course be considered as existing as part of a broader
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distribution, where people fall onto a spectrum of symptoms. However, providing clear boundaries in this case
enables us to initially consider the differences between people, which may relate to viable treatment options.
Another important caveat of cluster methods is that they examine shared variance and so we must remain
aware that any of the measures not included in this model could be highly relevant, but not share any
common features with the other measures. Additionally, in this cross-sectional work, the direction of causality
is impossible to infer: are people with low mood more susceptible to breathlessness anxiety or do they
become low in mood as a result of their greater symptom burden? Likewise, when considering links between
the latent factors and brain activity patterns, is high symptom burden a result of aberrant brain processes or a
driver of the patterns themselves? Longitudinal population studies would thus need to be employed to
understand any predominating direction within these relationships. Future studies could also consider using
resting state brain activity to examine the network dynamics underlying this difference. Finally, we suggest
that future work should include both detailed physiological and behavioural measures, which together could
better characterise breathlessness and unexplained variance in patient-reported outcomes.
This work opens up new avenues for improving patient treatment outcomes. First, the models developed
here could be tested for their ability to predict treatment outcomes. If all or some of the model factors were
shown to be therapeutically relevant, then their modulation could become the focus of targeted treatment
programmes. Second, the differences in brain activity patterns between the two groups could represent a
therapeutically relevant difference in breathlessness processing. The concept of “fooling the brain to treat
the lungs”, coined by SIMILOWSKI [89], highlights the importance of considering the brain as a target for the
treatment of breathlessness. In this instance, linking brain activity to therapeutic differences via latent
factors of breathlessness as demonstrated here is advantageous when considering the cost and restricted
applicability in the wider population of MRI scanning.
Conclusions
By combining neuroimaging, behavioural and clinical measures we have created an enriched model that
enables us to examine breathlessness from a multimodal perspective. In so doing we were able to stratify
participants, linking group differences in symptom burden to expectation-related brain activity within the
anterior insula, an area well recognised for processing breathlessness as well as internal bodily perceptions.
These findings potentially move us towards therapeutically relevant neuro-biomarkers and tailored treatment
programmes, which may together address the lived experience of breathlessness within an individual.
Author contributions: S.L. Finnegan: acquisition of data, analysis, interpretation, and drafting, editing
and approving the manuscript. O.K. Harrison: interpretation, and drafting, editing and approving the manuscript.
C.J. Harmer: study design, and editing and approving the manuscript. M. Herigstad: study design, acquisition of
data, and editing and approving the manuscript. N.M. Rahman: study design, and editing and approving the
manuscript. A. Reinecke: study design, and editing and approving the manuscript. K.T.S. Pattinson: study design,
interpretation, and editing and approving the manuscript.
Conflict of interest: S.L. Finnegan has nothing to disclose. O.K. Harrison has nothing to disclose. C.J. Harmer has
valueless shares in p1vital and serves on their advisory panel; has received consultancy payments from p1vital,
Servier, Eli-Lilly, AstraZeneca and Lundbeck; and is a director of Oxford Psychologists Ltd. M. Herigstad has
nothing to disclose. N.M. Rahman reports personal fees for consultancy from Rocket Medical UK, outside the
submitted work. A. Reinecke has nothing to disclose. K.T.S. Pattinson reports personal fees for consultancy from
Nektar Therapeutics, outside the submitted work; and has a patent UK patent application titled “Use of cerebral
nitric oxide donors in the assessment of the extent of brain dysfunction following injury” pending.
Support statement: This work was supported by the Dunhill Medical Trust (grant R333/0214) and the National
Institute for Health Research Biomedical Research Centre (grant RCF18/002) based at Oxford University Hospitals
NHS Foundation Trust and the University of Oxford. O.K. Harrison was supported via funding from the European
Union’s Horizon 2020 research and innovation programme under grant agreement number 793580, and a
Rutherford Discovery Fellowship awarded by the Royal Society of New Zealand. C.J. Harmer is supported by the
National Institute for Health Research Biomedical Research Centre based at Oxford Health NHS Foundation Trust
and the University of Oxford, and by the UK Medical Research Council. Funding information for this article has
been deposited with the Crossref Funder Registry.
References
1 Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome
of chronic breathlessness. Eur Respir J 2017; 49: 1602277.
https://doi.org/10.1183/13993003.04099-2020 12
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
2 Scano G, Gigliotti F, Stendardi L, et al. Dyspnea and emotional states in health and disease. Respir Med 2013;
107: 649–655.
3 Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on
the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435–452.
4 Stefan MS, Priya A, Martin B, et al. How well do patients and providers agree on the severity of dyspnea?
J Hosp Med 2016; 11: 701–707.
5 Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care
Med 2008; 178: 218–224.
6 Herigstad M, Faull OK, Hayen A, et al. Treating breathlessness via the brain: changes in brain activity over a
course of pulmonary rehabilitation. Eur Respir J 2017; 50: 1701029.
7 Herigstad M, Hayen A, Evans E, et al. Dyspnea-related cues engage the prefrontal cortex: evidence from
functional brain imaging in COPD. Chest 2015; 148: 953–961.
8 Esser RW, Stoeckel MC, Kirsten A, et al. Brain activation during perception and anticipation of dyspnea in
chronic obstructive pulmonary disease. Front Physiol 2017; 8: 617–617.
9 Esser RW, Stoeckel MC, Kirsten A, et al. Structural brain changes in patients with COPD. Chest 2016; 149:
426–434.
10 Finnegan SL, Pattinson KTS, Sundh J, et al. A common model for the breathlessness experience across
cardiorespiratory disease. ERJ Open Res 2021; 7: 00818-2020.
11 Wager TD, Atlas LY, Lindquist MA, et al. An fMRI-based neurologic signature of physical pain. N Engl J Med
2013; 368: 1388–1397.
12 Harrison OK, Hayen A, Wager TD, et al. Pain and breathlessness: salient, somatosensory and similar, but not
the same. bioRxiv 2020; preprint [https://doi.org/10.1101/2020.05.04.076174].
13 Mouraux A, Iannetti GD. The search for pain biomarkers in the human brain. Brain 2018; 141: 3290–3307.
14 Lee J, Mawla I, Kim J, et al. Machine learning-based prediction of clinical pain using multimodal
neuroimaging and autonomic metrics. Pain 2019; 160: 550–560.
15 Tracey I, Woolf CJ, Andrews NA. Composite pain biomarker signatures for objective assessment and effective
treatment. Neuron 2019; 101: 783–800.
16 Spruit MA, Augustin IML, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD:
multidimensional profiling. Eur Respir J 2015; 46: 1625–1635.
17 Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective
measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 2013; 187: 728–735.
18 Rosenkranz MA, Busse WW, Sheridan JF, et al. Are there neurophenotypes for asthma? Functional brain
imaging of the interaction between emotion and inflammation in asthma. PLoS One 2012; 7: e40921.
19 Yu L, De Mazancourt M, Hess A, et al. Functional connectivity and information flow of the respiratory neural
network in chronic obstructive pulmonary disease. Hum Brain Mapp 2016; 37: 2736–2754.
20 Nguyen DAT, Boswell-Ruys CL, McBain RA, et al. Inspiratory pre-motor potentials during quiet breathing in
ageing and chronic obstructive pulmonary disease. J Physiol 2018; 596: 6173–6189.
21 Vinckier F, Morélot-Panzini C, Similowski T. Dyspnoea modifies the recognition of fearful expressions by
healthy humans. Eur Respir J 2018; 51: 1702253.
22 Sucec J, Herzog M, Van Diest I, et al. The impairing effect of dyspnea on response inhibition. Int J
Psychophysiol 2018; 133: 41–49.
23 Peiffer C, Costes N, Hervé P, et al. Relief of dyspnea involves a characteristic brain activation and a specific
quality of sensation. Am J Respir Crit Care Med 2008; 177: 440–449.
24 Peiffer C, Poline JB, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J
Respir Crit Care Med 2001; 163: 951–957.
25 Hayen A, Wanigasekera V, Faull OK, et al. Opioid suppression of conditioned anticipatory brain responses to
breathlessness. Neuroimage 2017; 150: 383–394.
26 Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neuroreport 2000;
11: 2117–2120.
27 Liotti M, Brannan S, Egan G, et al. Brain responses associated with consciousness of breathlessness (air
hunger). Proc Natl Acad Sci USA 2001; 98: 2035–2040.
28 Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation
during air hunger. J Neurophysiol 2002; 88: 1500–1511.
29 Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of laboratory dyspnea: air hunger
is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177: 1384–1390.
30 Banzett RB, O’Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: an instrument for clinical
and laboratory research. Eur Respir J 2015; 45: 1681–1691.
31 Stevens JP, Sheridan AR, Bernstein HB, et al. A multidimensional profile of dyspnea in hospitalized patients.
Chest 2019; 156: 507–517.
https://doi.org/10.1183/13993003.04099-2020 13
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
32 Janssens T, Ritz T. Perceived triggers of asthma: key to symptom perception and management. Clin Exp
Allergy 2013; 43: 1000–1008.
33 Pagnini F. The potential role of illness expectations in the progression of medical diseases. BMC Psychol 2019;
7: 70.
34 Vlemincx E, Sprenger C, Büchel C. Expectation and dyspnea: the neurobiological basis of respiratory nocebo
effects. Eur Respir J 2021; 58: 2003008.
35 Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and
initial testing of the Dyspnoea-12. Thorax 2010; 65: 21–26.
36 Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl
Psychol Meas 1977; 1: 385–401.
37 Spielberger CD. State-Trait Anxiety Inventory. In: Weiner IB, Craighead WE, eds. The Corsini Encyclopedia of
Psychology. 4th Edn. Hoboken, Wiley, 2010; pp. 1698–1699.
38 Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale: application to patients with multiple
sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.
39 Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow
limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321–1327.
40 Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a
measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–586.
41 Chambless DL, Caputo GC, Jasin SE, et al. The Mobility Inventory for Agoraphobia. Behav Res Ther 1985; 23: 35–44.
42 Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric
practice and research. Psychiatry Res 1989; 28: 193–213.
43 De Peuter S, Lemaigre V, Van Diest I, et al. Illness-specific catastrophic thinking and overperception in
asthma. Health Psychol 2008; 27: 93–99.
44 McCracken LM, Vowles KE, Eccleston C. Acceptance-based treatment for persons with complex, long standing
chronic pain: a preliminary analysis of treatment outcome in comparison to a waiting phase. Behav Res Ther
2005; 43: 1335–1346.
45 Levy ML, Quanjer PH, Booker R, et al. Diagnostic spirometry in primary care: proposed standards for general
practice compliant with American Thoracic Society and European Respiratory Society recommendations: a
General Practice Airways Group (GPIAG) document, in association with the Association for Respiratory
Technology & Physiology (ARTP) and Education for Health. Prim Care Respir J 2009; 18: 130–147.
46 Bradley J, Howard J, Wallace E, et al. Validity of a modified shuttle test in adult cystic fibrosis. Thorax 1999;
54: 437–439.
47 Greco JA, Liberzon I. Neuroimaging of fear-associated learning. Neuropsychopharmacology 2016; 41: 320–334.
48 Britton JC, Grillon C, Lissek S, et al. Response to learned threat: an FMRI study in adolescent and adult
anxiety. Am J Psychiatry 2013; 170: 1195–1204.
49 Bulganin L, Bach D, Wittmann B. Prior fear conditioning and reward learning interact in fear and reward
networks. Front Behav Neurosci 2014; 8: 67.
50 Herigstad M, Hayen A, Reinecke A, et al. Development of a dyspnoea word cue set for studies of emotional
processing in COPD. Respir Physiol Neurobiol 2016; 223: 37–42.
51 Kaldewaij R, Reinecke A, Harmer CJ. A lack of differentiation in amygdala responses to fearful expression
intensity in panic disorder patients. Psychiatr Res Neuroimaging 2019; 291: 18–25.
52 Reinecke A, Waldenmaier L, Cooper MJ, et al. Changes in automatic threat processing precede and predict
clinical changes with exposure-based cognitive-behavior therapy for panic disorder. Biol Psychiatry 2013; 73:
1064–1070.
53 Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 2014;
43: 1750.
54 von Leupoldt A, Chan PY, Esser RW, et al. Emotions and neural processing of respiratory sensations
investigated with respiratory-related evoked potentials. Psychosom Med 2013; 75: 244–252.
55 Saraçli S, Doğan N, Doğan İ. Comparison of hierarchical cluster analysis methods by cophenetic correlation.
J Inequal Appl 2013; 2013: 203.
56 Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 236–244.
57 Fraley C, Raftery AE. Model-based clustering, discriminant analysis, and density estimation. J Am Stat Assoc
2002; 97: 611–631.
58 Schreiber JB, Nora A, Stage FK, et al. Reporting structural equation modeling and confirmatory factor
analysis results: a review. J Educ Res 2006; 99: 323–338.
59 Zygmont C, Smith M. Robust factor analysis in the presence of normality violations, missing data, and
outliers: empirical questions and possible solutions. Quant Methods Psychol 2014; 10: 40–55.
60 Costello AB, Osborne J. Best practices in exploratory factor analysis: four recommendations for getting the
most from your analysis. Pract Assess Res Eval 2005; 10: 7.
61 Winkler AM, Ridgway GR, Webster MA, et al. Permutation inference for the general linear model. Neuroimage
2014; 92: 381–397.
https://doi.org/10.1183/13993003.04099-2020 14
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
62 Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with
examples. Hum Brain Mapp 2002; 15: 1–25.
63 Phan KL, Fitzgerald DA, Nathan PJ, et al. Neural substrates for voluntary suppression of negative affect: a
functional magnetic resonance imaging study. Biol Psychiatry 2005; 57: 210–219.
64 Reinecke A, Filippini N, Berna C, et al. Effective emotion regulation strategies improve fMRI and ECG markers
of psychopathology in panic disorder: implications for psychological treatment action. Transl Psychiatry 2015;
5: e673.
65 Reinecke A, Nickless A, Browning M, et al. Neurocognitive processes in D-cycloserine augmented
single-session exposure therapy for anxiety: a randomized placebo-controlled trial. Behav Res Ther 2020; 129:
103607.
66 Faull OK, Pattinson KTS. The cortical connectivity of the periaqueductal gray and the conditioned response
to the threat of breathlessness. Elife 2017; 6: e21749.
67 Stoeckel MC, Esser RW, Gamer M, et al. Brain responses during the anticipation of dyspnea. Neural Plast
2016; 2016: 6434987.
68 von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnea is processed in the
anterior insula and amygdala. Am J Respir Crit Care Med 2008; 177: 1026–1032.
69 Tu Y, Fu Z, Mao C, et al. Distinct thalamocortical network dynamics are associated with the pathophysiology
of chronic low back pain. Nat Commun 2020; 11: 3948.
70 Jepma M, Koban L, van Doorn J, et al. Behavioural and neural evidence for self-reinforcing expectancy
effects on pain. Nat Hum Behav 2018; 2: 838–855.
71 Kucyi A, Davis KD. The dynamic pain connectome. Trends Neurosci 2015; 38: 86–95.
72 Mišić B, Sporns O. From regions to connections and networks: new bridges between brain and behavior.
Curr Opin Neurobiol 2016; 40: 1–7.
73 Spielberg JM, Miller GA, Heller W, et al. Flexible brain network reconfiguration supporting inhibitory control.
Proc Natl Acad Sci USA 2015; 112: 10020–10025.
74 Sporns O. Contributions and challenges for network models in cognitive neuroscience. Nat Neurosci 2014; 17:
652–660.
75 Kleckner IR, Zhang J, Touroutoglou A, et al. Evidence for a large-scale brain system supporting allostasis and
interoception in humans. Nat Hum Behav 2017; 1: 0069.
76 Wiech K, Tracey I. Pain, decisions, and actions: a motivational perspective. Front Neurosci 2013; 7: 46.
77 Mechias M-L, Etkin A, Kalisch R. A meta-analysis of instructed fear studies: Implications for conscious
appraisal of threat. Neuroimage 2010; 49: 1760–1768.
78 Craig AD. How do you feel – now? The anterior insula and human awareness. Nat Rev Neurosci 2009; 10:
59–70.
79 Kanwisher N, McDermott J, Chun MM. The fusiform face area: a module in human extrastriate cortex
specialized for face perception. J Neurosci 1997; 17: 4302–4311.
80 Dehaene S, Naccache L, Cohen L, et al. Cerebral mechanisms of word masking and unconscious repetition
priming. Nat Neurosci 2001; 4: 752–758.
81 Zhang W, Wang J, Fan L, et al. Functional organization of the fusiform gyrus revealed with connectivity
profiles. Hum Brain Mapp 2016; 37: 3003–3016.
82 Wheatley T, Weisberg J, Beauchamp MS, et al. Automatic priming of semantically related words reduces
activity in the fusiform gyrus. J Cogn Neurosci 2005; 17: 1871–1885.
83 Schindler S, Wegrzyn M, Steppacher I, et al. Perceived communicative context and emotional content amplify
visual word processing in the fusiform gyrus. J Neurosci 2015; 35: 6010–6019.
84 Kensinger EA, Schacter DL. Processing emotional pictures and words: effects of valence and arousal.
Cogn Affect Behav Neurosci 2006; 6: 110–126.
85 Carlson JM, Reinke KS, Habib R. A left amygdala mediated network for rapid orienting to masked fearful
faces. Neuropsychologia 2009; 47: 1386–1389.
86 Zhang M, Ma C, Luo Y, et al. Neural basis of uncertain cue processing in trait anxiety. Sci Rep 2016; 6: 21298.
87 Leminen A, Verwoert M, Moisala M, et al. Modulation of brain activity by selective attention to audiovisual
dialogues. Front Neurosci 2020; 14: 436.
88 Serences JT, Schwarzbach J, Courtney SM, et al. Control of object-based attention in human cortex. Cereb
Cortex 2004; 14: 1346–1357.
89 Similowski T. Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who
suffer from chronic respiratory diseases. Eur Respir J 2018; 51: 1800316.
https://doi.org/10.1183/13993003.04099-2020 15
EUROPEAN RESPIRATORY JOURNAL ORIGINAL RESEARCH ARTICLE | S.L. FINNEGAN ET AL.
